Chien‐Hung Chen

5.4k total citations
114 papers, 3.3k citations indexed

About

Chien‐Hung Chen is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Chien‐Hung Chen has authored 114 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 38 papers in Epidemiology and 22 papers in Oncology. Recurrent topics in Chien‐Hung Chen's work include Liver Disease Diagnosis and Treatment (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Hepatitis B Virus Studies (19 papers). Chien‐Hung Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Hepatitis B Virus Studies (19 papers). Chien‐Hung Chen collaborates with scholars based in Taiwan, United States and Japan. Chien‐Hung Chen's co-authors include Chen‐Chia Huang, Jin‐Chuan Sheu, T.‐C. Wu, Ding‐Shinn Chen, Guan‐Tarn Huang, Hongsong Li, Chi‐Sin Changchien, Mei–Hsuan Lee, Sheng‐Nan Lu and Drew M. Pardoll and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Chien‐Hung Chen

107 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien‐Hung Chen Taiwan 34 1.1k 1.1k 585 471 407 114 3.3k
Yu‐Chen Fan China 30 641 0.6× 900 0.8× 715 1.2× 541 1.1× 307 0.8× 176 2.9k
Zhenli Li China 25 641 0.6× 396 0.4× 584 1.0× 303 0.6× 351 0.9× 103 2.5k
Xiaoyu Yin China 27 591 0.5× 397 0.4× 824 1.4× 354 0.8× 233 0.6× 133 2.9k
Claudia Schmidt Germany 31 842 0.7× 324 0.3× 1.3k 2.2× 418 0.9× 238 0.6× 83 3.9k
Sung Kyu Choi South Korea 29 798 0.7× 635 0.6× 303 0.5× 107 0.2× 811 2.0× 209 3.7k
David R. Vera United States 33 498 0.4× 499 0.4× 582 1.0× 162 0.3× 202 0.5× 118 3.1k
Tse‐Ching Chen Taiwan 40 470 0.4× 991 0.9× 1.2k 2.0× 675 1.4× 213 0.5× 192 4.8k
Takashi Ito Japan 36 1.6k 1.4× 709 0.6× 395 0.7× 98 0.2× 141 0.3× 248 4.9k
Xiaochen Sun China 29 412 0.4× 600 0.5× 711 1.2× 106 0.2× 1.1k 2.6× 104 3.9k
Martin Schilling Germany 38 522 0.5× 441 0.4× 1.2k 2.0× 609 1.3× 163 0.4× 204 4.5k

Countries citing papers authored by Chien‐Hung Chen

Since Specialization
Citations

This map shows the geographic impact of Chien‐Hung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Hung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Hung Chen more than expected).

Fields of papers citing papers by Chien‐Hung Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Hung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Hung Chen. The network helps show where Chien‐Hung Chen may publish in the future.

Co-authorship network of co-authors of Chien‐Hung Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Hung Chen. A scholar is included among the top collaborators of Chien‐Hung Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Hung Chen. Chien‐Hung Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Ja‐Der, Po‐Chin Liang, Chia‐Tung Shun, et al.. (2025). In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 1191–1204.
2.
Chen, Chien‐Hung, et al.. (2024). Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas. Journal of the Formosan Medical Association. 123(5). 613–619. 2 indexed citations
4.
Lin, Chih‐Yun, Yi‐Hao Yen, Jing‐Houng Wang, et al.. (2022). Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information. Journal of the Formosan Medical Association. 121(10). 2085–2092. 4 indexed citations
5.
Liu, Yi‐Sheng, et al.. (2022). Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T). SHILAP Revista de lepidopterología. Volume 9. 811–821. 1 indexed citations
6.
Kuo, Chia‐Chi, et al.. (2020). Hepatocellular Carcinoma With Pleural Metastases Without Residual Liver Tumor Diagnosed by Pleuroscopy. Archivos de Bronconeumología. 57(5). 370–370.
7.
Huang, Chun‐Chieh, Chao‐Hung Hung, Po‐Chin Liang, et al.. (2018). Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer. 7(4). 312–322. 13 indexed citations
8.
Chang, Chia-Hsieh, et al.. (2014). Flatfoot Diagnosis by a Unique Bimodal Distribution of Footprint Index in Children. PLoS ONE. 9(12). e115808–e115808. 34 indexed citations
9.
Ho, Cheng‐Maw, Yen‐Chun Liu, Yao‐Ming Wu, et al.. (2014). Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma. PLoS ONE. 9(2). e89446–e89446. 51 indexed citations
10.
Hsu, Chung-Hua, et al.. (2012). The Relationship between Qi Deficiency, Cancer-related Fatigue and Quality of Life in Cancer Patients. SHILAP Revista de lepidopterología. 2(2). 129–135. 22 indexed citations
11.
Lien, Huang‐Chun, et al.. (2010). An Unusual Retroperitoneal Tumor in a Young Woman. Gastroenterology. 139(6). 1836–2227.
12.
Chen, Chien‐Hung, Fu-Chang Hu, Guan‐Tarn Huang, et al.. (2009). Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients. European Journal of Cancer. 45(9). 1630–1639. 64 indexed citations
13.
Chang, Ken‐Hui & Chien‐Hung Chen. (2009). MTBE concentration profiles near MTBE manufacturing plant: Modeling approach and modeling uncertainty. Chemosphere. 75(10). 1322–1328. 3 indexed citations
14.
Ho, Ming‐Chih, Guan‐Tarn Huang, Po‐Huang Lee, et al.. (2009). Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas. Annals of Surgical Oncology. 16(4). 848–855. 99 indexed citations
15.
Wu, Shang‐Ju, Chien‐Ching Hung, Chien‐Hung Chen, & Hwei‐Fang Tien. (2008). Primary effusion lymphoma in three patients with chronic hepatitis B infection. Journal of Clinical Virology. 44(1). 81–83. 11 indexed citations
16.
Hsieh, Pei-Ying, et al.. (2007). Primary Effusion Lymphoma Involving both Pleural and Abdominal Cavities in a Patient with Hepatitis B Virus-related Liver Cirrhosis. Journal of the Formosan Medical Association. 106(6). 504–508. 7 indexed citations
17.
Lu, Sheng‐Nan, Wei‐Wen Su, Sheng‐Shun Yang, et al.. (2006). Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan. International Journal of Cancer. 119(8). 1946–1952. 111 indexed citations
18.
Chen, Chien‐Hung, Tian‐Li Wang, Chien‐Fu Hung, Drew M. Pardoll, & T.‐C. Wu. (2000). Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines. Vaccine. 18(19). 2015–2022. 73 indexed citations
19.
Chen, Chien‐Hung. (1998). Learning Effects and Convergence in the Production of Japanese Rice. Journal of Rural Problems. 34(1). 1–9. 1 indexed citations
20.
Chen, Chien‐Hung & T.‐C. Wu. (1998). Experimental Vaccine Strategies for Cancer Immunotherapy. Journal of Biomedical Science. 5(4). 231–252. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026